Novel CS1 CAR-T Cells and Bispecific CS1-BCMA CAR-T Cells Effectively Target Multiple Myeloma

被引：14
|
作者：
Golubovskaya, Vita [1 ]
Zhou, Hua [1 ]
Li, Feng [1 ,2 ]
Berahovich, Robert [1 ]
Sun, Jinying [1 ]
Valentine, Michael [1 ]
Xu, Shirley [1 ]
Harto, Hizkia [1 ]
Sienkiewicz, John [1 ]
Huang, Yanwei [1 ]
Wu, Lijun [1 ,3 ]
机构：
[1] Promab Biotechnol, 2600 Hilltop Dr, Richmond, CA 94806 USA
[2] Hunan Univ Arts & Sci, Biol & Environm Sci Coll, Changde 415000, Peoples R China
[3] Forevertek Biotechnol, Janshan Rd, Changsha 410205, Peoples R China
来源：
BIOMEDICINES | 2021年 / 9卷 / 10期
关键词：
chimeric antigen receptor; CAR-T cells; CS1; BCMA; immunotherapy; cell therapy; tumor antigen; multiple myeloma; MATURATION ANTIGEN; RECEPTOR; THERAPY; CANCER; IMMUNOTHERAPY; SYSTEM; APRIL; BAFF; TACI; BCMA;
D O I：
10.3390/biomedicines9101422
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Multiple myeloma (MM) is a hematological cancer caused by abnormal proliferation of plasma cells in the bone marrow, and novel types of treatment are needed for this deadly disease. In this study, we aimed to develop novel CS1 CAR-T cells and bispecific CS1-BCMA CAR-T cells to specifically target multiple myeloma. We generated a new CS1 (CD319, SLAM-7) antibody, clone (7A8D5), which specifically recognized the CS1 antigen, and we applied it for the generation of CS1-CAR. CS1-CAR-T cells caused specific killing of CHO-CS1 target cells with secretion of IFN-gamma and targeted multiple myeloma cells. In addition, bispecific CS1-BCMA-41BB-CD3 CAR-T cells effectively killed CHO-CS1 and CHO-BCMA target cells, killed CS1/BCMA-positive multiple myeloma cells, and secreted IFN-gamma. Moreover, CS1-CAR-T cells and bispecific CS1-BCMA CAR-T cells effectively blocked MM1S multiple myeloma tumor growth in vivo. These data for the first time demonstrate that novel CS1 and bispecific CS1-BCMA-CAR-T cells are effective in targeting MM cells and provide a basis for future clinical trials.
引用
收藏
页数：11
相关论文
共 50 条
  • [41] Engineering CAR-T cells
    Cheng Zhang
    Jun Liu
    Jiang F. Zhong
    Xi Zhang
    Biomarker Research, 5
  • [42] Impact of corticosteroids on efficacy of BCMA targeted CAR-T therapy in multiple myeloma
    Duvalyan, Eva
    Shah, Nina
    Lo, Mimi
    Martin III, Thomas
    Wolf, Jeffrey L.
    Chung, Alfred
    Arora, Shagun
    Huang, Chiung-Yu
    Wong, Sandy W.
    LEUKEMIA & LYMPHOMA, 2023,
  • [43] Reconstitution of the Multiple Myeloma Microenvironment Following Lymphodepletion with BCMA CAR-T Therapy
    Yang, Yazi
    Qin, Sen
    Yang, Mengyu
    Wang, Ting
    Feng, Ru
    Zhang, Chunli
    Zheng, Enrun
    Li, Qinghua
    Xiang, Pengyu
    Ning, Shangyong
    Xu, Xiaodong
    Zuo, Xin
    Zhang, Shuai
    Yun, Xiaoya
    Zhou, Xuehong
    Wang, Yue
    He, Lin
    Shang, Yongfeng
    Sun, Luyang
    Liu, Hui
    CLINICAL CANCER RESEARCH, 2024, 30 (18) : 4201 - 4214
  • [44] Impact of corticosteroids on efficacy of BCMA targeted CAR-T therapy in multiple myeloma
    Duvalyan, Eva
    Shah, Nina
    Lo, Mimi
    Martin III, Thomas
    Wolf, Jeffrey L.
    Chung, Alfred
    Arora, Shagun
    Huang, Chiung-Yu
    Wong, Sandy W.
    LEUKEMIA & LYMPHOMA, 2023,
  • [45] CAR-T cells in the treatment of multiple myeloma: an encouraging cell therapy
    Yu, Tong
    Jiao, Jian-Hang
    Wu, Min-Fei
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [46] Impact of Corticosteroids on Efficacy of BCMA Targeted CAR-T Therapy in Multiple Myeloma
    Duvalyan, Eva
    Lo, Mimi
    Martin, Thomas
    Wolf, Jeffrey L.
    Chung, Alfred
    Arora, Shagun
    Shah, Nina
    Huang, Chiung-Yu
    Wong, Sandy W.
    BLOOD, 2021, 138
  • [47] DIRECTED IMMUNOTHERAPY: CAR-T STUDY AGAINST BCMA FOR THE TREATMENT OF MULTIPLE MYELOMA
    Perez Amill, L.
    Sune, G.
    Castella, M.
    Urbano Ispizua, A.
    Martin Antonio, B.
    HAEMATOLOGICA, 2017, 102 : 52 - 52
  • [48] CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells
    Davenport, Alexander J.
    Jenkins, Misty R.
    Cross, Ryan S.
    Yong, Carmen S.
    Prince, H. Miles
    Ritchie, David S.
    Trapani, Joseph A.
    Kershaw, Michael H.
    Darcy, Phillip K.
    Neeson, Paul J.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (05) : 483 - 494
  • [49] Real-world comparison of overall survival between BCMA - bispecific and CAR-T therapies in multiple myeloma
    Song, J.
    Kim, G.
    Memon, R. S.
    Chi, K-Y.
    Chang, Y.
    Mehta, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S597 - S597
  • [50] Novel targets and technologies for CAR-T cells in multiple myeloma and acute myeloid leukemia
    Prommersberger, Sabrina
    Jetani, Hardikkumar
    Danhof, Sophia
    Monjezi, Razieh
    Nerreter, Thomas
    Beckmann, Julia
    Einsele, Herrmann
    Hudecek, Michael
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2018, 66 (02) : 37 - 38
12345